IQVIA to Announce Fourth-Quarter and Full-Year 2024 Results on February 6, 2025
IQVIA Holdings (NYSE:IQV) has scheduled its fourth-quarter and full-year 2024 financial results announcement for Thursday, February 6, 2025, before market opening. The management team will host a conference call and webcast at 9:00 a.m. Eastern Time on the same day.
The earnings release and financial information will be available on IQVIA's Investor Relations website. Interested parties must register in advance to participate in the conference call, after which they will receive confirmation details including dial-in information and unique access credentials. A webcast replay will be accessible approximately two hours after the event conclusion.
IQVIA Holdings (NYSE:IQV) ha programmato la pubblicazione dei risultati finanziari del quarto trimestre e dell'intero anno 2024 per giovedì 6 febbraio 2025, prima dell'apertura del mercato. Il team di management ospiterà una teleconferenza e una trasmissione in diretta alle 9:00 a.m. Eastern Time lo stesso giorno.
Il comunicato sugli utili e le informazioni finanziarie saranno disponibili sul sito web delle Relazioni con gli Investitori di IQVIA. Le parti interessate dovranno registrarsi in anticipo per partecipare alla teleconferenza, dopo di che riceveranno i dettagli di conferma, inclusi le informazioni per la chiamata e le credenziali di accesso uniche. Una registrazione della trasmissione sarà accessibile circa due ore dopo la conclusione dell'evento.
IQVIA Holdings (NYSE:IQV) ha programado el anuncio de sus resultados financieros del cuarto trimestre y del año completo 2024 para el jueves 6 de febrero de 2025, antes de la apertura del mercado. El equipo de gestión llevará a cabo una llamada de conferencia y una transmisión web a las 9:00 a.m. hora del Este del mismo día.
El comunicado de ganancias y la información financiera estarán disponibles en el sitio web de Relaciones con Inversores de IQVIA. Las partes interesadas deben registrarse con anticipación para participar en la llamada de conferencia, después de lo cual recibirán detalles de confirmación que incluirán información de acceso telefónico y credenciales de acceso únicas. Una repetición de la transmisión estará accesible aproximadamente dos horas después de la conclusión del evento.
IQVIA Holdings (NYSE:IQV)는 2025년 2월 6일 목요일에 시장 개장 전에 2024년 4분기 및 전체 연도 재무 결과 발표를 예정하고 있습니다. 경영진 팀은 같은 날 동부 표준시 기준 오전 9:00에 전화 회의와 웹캐스트를 진행합니다.
실적 발표와 재무 정보는 IQVIA의 투자자 관계 웹사이트에서 확인할 수 있습니다. 관심 있는 당사자는 전화 회의에 참여하기 위해 사전 등록해야 하며, 이후 전화 접속 정보 및 고유 접근 자격을 포함한 확인 세부정보를 받게 됩니다. 이벤트 종료 후 약 두 시간 뒤에 웹캐스트 재생이 가능합니다.
IQVIA Holdings (NYSE:IQV) a prévu l'annonce de ses résultats financiers du quatrième trimestre et de l'année complète 2024 pour jeudi 6 février 2025, avant l'ouverture des marchés. L'équipe de direction animera une conférence téléphonique et un webinaire le même jour à 9h00 heure de l'Est.
Le communiqué de résultats et les informations financières seront disponibles sur le site Web des Relations Investisseurs d'IQVIA. Les parties intéressées doivent s'inscrire à l'avance pour participer à la conférence téléphonique, après quoi elles recevront des détails de confirmation comprenant des informations d'appel et des identifiants d'accès uniques. Un replay du webinaire sera accessible environ deux heures après la conclusion de l'événement.
IQVIA Holdings (NYSE:IQV) hat die Bekanntgabe seiner Finanzzahlen für das vierte Quartal und das gesamte Jahr 2024 für Donnerstag, den 6. Februar 2025, vor Markteröffnung angesetzt. Das Managementteam wird am selben Tag um 9:00 Uhr Eastern Time eine Telefonkonferenz und einen Webcast veranstalten.
Die Gewinnmitteilung und finanziellen Informationen werden auf der Investor-Relations-Website von IQVIA verfügbar sein. Interessierte Personen müssen sich im Voraus registrieren, um an der Telefonkonferenz teilzunehmen, nach der sie Bestätigungsdetails, einschließlich Einwahlinformationen und einzigartiger Zugangsdaten, erhalten. Eine Aufzeichnung des Webcasts wird etwa zwei Stunden nach Abschluss der Veranstaltung zugänglich sein.
- None.
- None.
To listen to the event and view the presentation slides via webcast, join from the IQVIA Investor Relations website at http://ir.iqvia.com. To participate in the conference call, interested parties must register in advance by clicking on this link. Following registration, participants will receive a confirmation email containing details on how to join the conference call, including the dial-in and a unique passcode and registrant ID. At the time of the live event, registered participants can connect to the call using the information provided in the confirmation email and will be placed directly into the call.
A replay of the webcast will be available approximately two hours after the conclusion of the live event. To access the webcast recording, visit http://ir.iqvia.com.
About IQVIA
IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI™, advanced analytics, the latest technologies and extensive domain expertise. With approximately 88,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide.
IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.
IQVIAFIN
View source version on businesswire.com: https://www.businesswire.com/news/home/20250121201083/en/
Kerri Joseph, IQVIA Investor Relations (kerri.joseph@iqvia.com)
+1.973.541.3558
Alissa Maupin, IQVIA Media Relations (alissa.maupin1@iqvia.com)
+1.919.923.6785
Source: IQVIA
FAQ
When will IQVIA (IQV) release its Q4 and full-year 2024 earnings?
What time is IQVIA's (IQV) Q4 2024 earnings conference call?
How can investors access IQVIA's (IQV) Q4 2024 earnings webcast?